Pharmacy Times
JULY 29, 2022
The immune responses to the Omicron variant waned substantially with neutralizing antibody levels decreasing 2.4- to 5.3-fold by 3 months after the booster dose.
Pharmaceutical Technology
JULY 29, 2022
Pfizer has reported a 53% operational growth in revenues to $27.7bn in the second quarter (Q2) of 2022 compared to $18.9bn in the same quarter last year. The rise in revenues was chiefly driven by robust contributions from Covid-19 therapies Paxlovid and Comirnaty. On an operational basis, the revenues rose by $128m or 1%, excluding Paxlovid and Comirnaty’s contributions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 29, 2022
A majority of long-term care patients who received a fourth vaccination against COVID-19 were found to have increased protection against the omicron variant.
Pharmaceutical Technology
JULY 29, 2022
The rate at which children are being identified with autism spectrum disorder (ASD) has tripled in the past two decades. While the prevalence was 1 in 150 children in 2000, it reached the rate of 1 in 44 in 2018, in the US, according to the Centers for Disease Control and Prevention. Some people with ASD can experience acute agitation and crisis behaviours.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JULY 29, 2022
The pandemic saw reductions in the supply of methadone but no disruption to the supply of more easily accessible buprenorphine, though disparities in supply were observed across states.
European Pharmaceutical Review
JULY 29, 2022
Researchers have constructed biohybrid microrobots, by equipping Escherichia coli bacteria with artificial components, that could one day offer a highly targeted and effective cancer treatment option. The team of scientists from the Physical Intelligence Department at the Max Planck Institute for Intelligent Systems combined robotics with E. coli bacteria to construct their innovative drug delivery system.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmaceutical Technology
JULY 29, 2022
Schizophrenia Awareness Day, marked on 25 July, is a national observance that aims to raise awareness about this mental illness. Schizophrenia is a chronic brain disorder that affects a person’s ability to function, such as thinking and feeling. According to GlobalData’s Epidemiology and Market Size database, epidemiologists estimate there are more than 21 million prevalent cases within the tracked 16 countries.
Pharmacy Times
JULY 29, 2022
The findings of the phase 1b/2 CHRYSALIS-2 cohort will be presented at the International Association for the Study of Lung Cancer 2022 World Conference on Lung Cancer.
European Pharmaceutical Review
JULY 29, 2022
Both the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have endorsed a statement calling for international collaboration on integrating real-world evidence (RWE) into regulatory decision-making. The statement, published by the International Coalition of Medicines Regulatory Authorities (ICMRA), describes how collaboration between regulators and researchers that formed a critical aspect of the world’s COVID-19 response could be leveraged to enhance medicines regulatio
Pharmacy Times
JULY 29, 2022
It’s common practice to recommend heart failure patients follow low sodium diets, but research has shown this type of diet may worsen patient health for certain forms of the condition.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
JULY 29, 2022
Last week, CAMP4 Therapeutics announced the close of a $100 million Series B round , which will be used to advance their regulatory RNA (regRNA)-focused programs. Their use of regRNA technology provides a unique approach to treating rare conditions like urea cycle disorders. CAMP4’s CSO David Bumcrot PhD tells Pharmaceutical Technology that the company plans to see clinical trials go forward for their urea cycle disorder programs late next year.
Pharmacy Times
JULY 29, 2022
Government’s database include health care professionals in many categories, including pharmacists.
Pharmaceutical Commerce
JULY 29, 2022
OptimizeRx’s Steve Silvestro on how the healthcare sector is performing when it comes to patient care, and how the use of technology can positively impact that process.
Pharmacy Times
JULY 29, 2022
Evolutionary vaccine technologies driven by the COVID-19 pandemic are explored in a discussion led by Dr Cohen.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JULY 29, 2022
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional, and global life science communications to offer some little tips for enjoying a big business career. This post recommends setting aside regular time for reflection to critically think through major opportunities, projects and issues in order to make well-considered, high-quality decisions.
Pharmacy Times
JULY 29, 2022
L-Lysine is a protein source that supports collagen synthesis.
pharmaphorum
JULY 29, 2022
Patients with end-stage renal disease (ESRD) who are on dialysis often need to be treated with anticoagulants to prevent blood clots, but as a result, can experience bleeding side effects. Now, Ionis and Bayer think they have a new drug that could sidestep that risk. In a phase 2b RE-THINC trial, their experimental antisense-based Factor XI inhibitor fesomersen was able to achieve a “substantial and statistically significant” reduction in levels of the clotting factor, indicating it
Pharmacy Times
JULY 29, 2022
Fondaparinux sodium (Arixtra) is indicated for prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip fracture surgery (including extended prophylaxis), hip replacement surgery, knee replacement surgery, or abdominal surgery.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmExec
JULY 29, 2022
The use of biometric data and novel digital biomarkers in the administration of CAT-T therapy can both improve the safety profile and reduce patient burden of cancer treatment. Jaydev Thakkar, Chief Operating Officer at Biofourmis, will share how this data paired with clinical-grade algorithms can predict the onset of adverse events to allow for proactive intervention and improved patient outcomes.
Pharmacy Times
JULY 29, 2022
This month, we spoke with Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, about ketamine and the future of the opioid epidemic.
PharmExec
JULY 29, 2022
Tealium for Pharma utilizes deep integration technology and partnerships to deliver an enhanced customer journey in one of healthcare's most vital sectors.
Pharmacy Times
JULY 29, 2022
Study shows that adult survivors of cancer had a 42% greater risk of CVD than people who did not have the disease.
Viseven
JULY 29, 2022
Email is one of the core channels for building and developing communication between pharma brands, patients, and HCPs. As a marketing tool, email allows delivering well-targeted messages to the recipients, highlighting the key point of your emails and it is a fast and simple way to communicate with your target audience. Thoughtfully designed email campaigns may benefit pharma brand image in multiple ways: Increase brand awareness Increase sales Develop trust Increase traffic Communication automa
Compounding Pharmacy of America
JULY 29, 2022
Palliative care is not a treatment to reduce or eliminate the condition or disease. It is a pain management process for those living with a serious, oftentimes life threatening illness. Through palliative care, patients and their families can focus on a comfortable quality of life. Discussing palliative care does not always mean a lack of […].
Pharmacy Times
JULY 29, 2022
There is nothing that hurts us more when a pharmacist stands up and is not passionate about the job that we do and the care that we provide.
The Honest Apothecary
JULY 29, 2022
I have noticed a tendency in some otherwise great healthcare leaders throughout my career to fall short of the influence they might have had by failing to, as I see it, balance passion and patience. Too much of one, or too little of the other, makes a lopsided leader whose impact can suddenly derail. Allow me to elaborate on this a bit, and try to offer some advice from my own experience.
Pharmaceutical Commerce
JULY 29, 2022
The latest people news happenings over the past month.
Pharmaceutical Technology
JULY 29, 2022
Novartis has expanded its research-based partnership with the University of California, Berkeley, US, to discover new therapeutic modalities and address ‘undruggable’ disease targets. Based on the successes over the last five years, the alliance will develop new technologies to discover next-generation therapies. The merged team of researchers is analysing various disease targets in cancer, as well as other ailments that have escaped conventional small-molecule compounds and drug discovery app
Pharma Times
JULY 29, 2022
The phase 1/2 study is for patients with advanced or metastatic solid tumours
Pharmaceutical Technology
JULY 29, 2022
The clinical trial industry has seen a significant transformation over the years owing to the increased adoption of hybrid and decentralized models. The availability of digital technologies that support these models has made it possible for a larger pool of patients to participate in trials. However, there remains a key area of patient participation that is lagging digitally, says Andrés Escallón, Vice President of eClinical Innovation at Suvoda.
Pharma Times
JULY 29, 2022
Investment is a key boost to the acceleration of treatment access in the UK
PharmExec
JULY 29, 2022
Luckie Health will provide data-centric marketing solutions for healthcare companies.
Expert insights. Personalized for you.
181 
Let's personalize your content